Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1700 participants.

Also called NCT07164859

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,700 participants (planned count) (from the registry)
Sponsor
Vincent ROULE (from the registry)
Registry
  • NCT NCT07164859
  • EU CT 2023-507545-28-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07164859. Randomized; single masking; primary purpose treatment. Start 2026-03-03 (actual); primary completion 2029-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
Acronym
SOLOPCI
Condition
Antiplatelet Therapy
Condition
Elderly (People Aged 65 or More)
Intervention (Drug)
short dual antiplatelet therapy (DAPT) duration
Intervention (Drug)
Standard DAPT duration
Lead sponsor
Vincent ROULE (class: other)

Record details

Record id
cardio:ct-nct07164859
Content hash
a2bcf358698f8b3ca5e398c525e33edda753ae27bc31a123ff04922f2f415ce5